<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05019833</url>
  </required_header>
  <id_info>
    <org_study_id>ICRI01</org_study_id>
    <nct_id>NCT05019833</nct_id>
  </id_info>
  <brief_title>Collection of SPOT EGMs And inTra-Cardiac Impedance for Atrio-ventricUlar and inteR-ventricular Delays optimizatioN</brief_title>
  <acronym>SATURN</acronym>
  <official_title>Collection of SPOT EGMs And inTra-Cardiac Impedance for Atrio-ventricUlar and inteR-ventricular Delays optimizatioN</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>MicroPort CRM</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>MicroPort CRM</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to collect data from the two implanted sensors simultaneously to&#xD;
      the surface ECG and echocardiographic measurements of electromechanical parameters, in CRT&#xD;
      patients.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The SATURN study is a prospective, interventional, open-label, non-randomized, single-arm,&#xD;
      acute, multicenter feasibility study.&#xD;
&#xD;
      The purpose of the study is to collect data from the two implanted sensors simultaneously to&#xD;
      the surface ECG and echocardiographic measurements of electromechanical parameters.&#xD;
&#xD;
      The data collected will be analysed in order to explore the relevance of timings and&#xD;
      morphological features derived from those signals in comparison with timings determined on&#xD;
      echocardiography and electrocardiograms (ECG) in various configurations of atrioventricular&#xD;
      (AV) and inter-ventricular (VV) delays.&#xD;
&#xD;
      A maximum of 35 subjects, implanted with a CRT-D device, will be enrolled, at approximately 6&#xD;
      sites in France. Each patient will participate to this study only during an echocardiographic&#xD;
      procedure, whose duration is estimated in approximately 1.5 hour.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 2021</start_date>
  <completion_date type="Anticipated">June 2022</completion_date>
  <primary_completion_date type="Anticipated">June 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Signals timing vs LPEI</measure>
    <time_frame>Participants will be tested during a single clinic visit, at the enrolment in the study (Day 0)</time_frame>
    <description>An exploratory analysis on the relation between timings derived from the signals acquired with CRT implanted devices, and LPEI (Left Pre-Ejection Interval) determined by echography in multiple configurations of atrio-ventricular (AV) and inter-ventricular (VV) delays.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">35</enrollment>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>Signals collection</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Collection of sensors signals by the implanted device.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Signals collection</intervention_name>
    <description>A non-CE marked embedded software will be temporarily uploaded in the implanted device, in order to enable the collection of sensors signals.</description>
    <arm_group_label>Signals collection</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient with class I or II indication for implantation of a CRT-D device according to&#xD;
             current ESC guidelines&#xD;
&#xD;
          -  Patient newly implanted with a MicroPort CRM Platinium CRT-D SonR or Platinium CRT-D&#xD;
             device within 2 months before the Investigational Procedure&#xD;
&#xD;
          -  Patient in sinus rhythm with a preserved atrio-ventricular conduction, and PR&#xD;
             interval=220 +/- 30 ms on surface ECG&#xD;
&#xD;
          -  Patient has reviewed, signed and dated the study informed consent form&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient with permanent or persistent atrial fibrillation or atrial flutter&#xD;
&#xD;
          -  Patient presenting with a permanent or frequent paroxysmal high degree&#xD;
             atrio-ventricular block&#xD;
&#xD;
          -  Device upgrade or replacement&#xD;
&#xD;
          -  Minor patient (i.e. under 18 years of age), or patient under guardianship or kept in&#xD;
             detention&#xD;
&#xD;
          -  Patient unavailable for the scheduled Investigational Procedure, not able to&#xD;
             understand the purpose of this study or refusing to cooperate&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Erwan Donal, Pr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU Pontchaillou - Rennes, France</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Alberto Borri Brunetto</last_name>
    <phone>+39 335 6997104</phone>
    <email>alberto.borri.brunetto@crm.microport.com</email>
  </overall_contact>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>July 28, 2021</study_first_submitted>
  <study_first_submitted_qc>August 19, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 25, 2021</study_first_posted>
  <last_update_submitted>August 19, 2021</last_update_submitted>
  <last_update_submitted_qc>August 19, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 25, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

